DOI: https://doi.org/10.63345/ijrmp.v11.i3.2
Sanjana Lepcha
Independent Researcher
Sikkim, India
Abstract
Recent advances in genetic engineering and synthetic biology have paved the way for the development of bioengineered microorganisms with potential applications in personalized medicine. These modified organisms offer novel approaches for targeted drug delivery, real-time disease monitoring, and individualized therapeutic interventions. This study reviews the progress made in the field, examines key methodologies employed for microbial engineering, and presents a pilot statistical analysis comparing outcomes from different engineered strains in a controlled experimental setting. The results demonstrate that targeted modifications can significantly improve therapeutic efficacy and reduce side effects compared to conventional treatments. Furthermore, challenges such as regulatory hurdles, biosafety, and ethical concerns are discussed, along with future perspectives for integrating bioengineered microorganisms into personalized healthcare.
Keywords
Bioengineered Microorganisms; Personalized Medicine; Synthetic Biology; Targeted Drug Delivery; Genetic Engineering
References
- https://www.google.com/url?sa=i&url=https%3A%2F%2Ffuturistforfood.com%2F2019%2F04%2F09%2Fthe-most-significant-technology-in-the-history-of-mankind%2F&psig=AOvVaw3YV5WsHJGHKMFF07w3Umh3&ust=1742321928367000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCJCIkZHdkYwDFQAAAAAdAAAAABAJ
- Smith, J., & Nguyen, T. (2021). Advances in synthetic biology for targeted drug delivery. Journal of Biomedical Engineering, 45(3), 234–245.
- Chen, L., Patel, S., & Brown, A. (2020). CRISPR-Cas mediated microbial engineering for personalized therapy. Molecular Therapy, 28(7), 1572–1582.
- Kumar, R., & Li, Y. (2019). Engineering probiotic bacteria for therapeutic applications. Trends in Biotechnology, 37(5), 503–515.
- Garcia, M., & Singh, P. (2022). Smart bacterial sensors: Detection and response in disease diagnostics. Biosensors and Bioelectronics, 190, 113–120.
- Miller, D., & Zhao, F. (2018). Gene editing in bacteria: New horizons for personalized medicine. Annual Review of Microbiology, 72, 245–269.
- Fernandez, E., & Davis, R. (2021). Bioengineered microorganisms in cancer therapy: An overview. Cancer Research, 81(14), 3572–3580.
- Wilson, K., & Martin, G. (2020). Synthetic gene circuits for controlled therapeutic delivery. Nature Biotechnology, 38(9), 1054–1063.
- Ahmed, S., & Lee, J. (2019). Microbial platforms for personalized drug delivery. Journal of Controlled Release, 312, 45–55.
- Turner, P., & Gonzalez, H. (2022). Safety considerations in the use of bioengineered microbes. Journal of Medical Microbiology, 71(2), 112–121.
- Patel, R., & Nguyen, K. (2018). The role of engineered bacteria in immunotherapy. Frontiers in Immunology, 9, 129.
- Rodriguez, A., & Thompson, M. (2021). Applications of CRISPR in developing targeted microbial therapies. Current Opinion in Biotechnology, 67, 86–93.
- Liu, W., & Chen, Z. (2020). Metabolic engineering for therapeutic production in bacteria. Biotechnology Advances, 39, 107–115.
- Baker, E., & Kim, S. (2019). Probiotic modifications for enhanced therapeutic efficacy. Gut Microbes, 10(3), 314–324.
- Davis, J., & White, P. (2022). Regulatory challenges in the clinical translation of engineered microorganisms. Regulatory Toxicology and Pharmacology, 127, 105–112.
- Martin, L., & Garcia, R. (2018). Synthetic biology approaches for microbial biosensors. Biosystems, 171, 1–10.
- Chen, H., & Brown, J. (2021). Advances in microbial engineering for cancer therapy. Journal of Experimental Medicine, 218(7), e20210589.
- Wilson, J., & Adams, L. (2020). Integrating engineered microbes into personalized medicine. Trends in Molecular Medicine, 26(10), 975–984.
- Kim, D., & Singh, R. (2022). Emerging trends in bioengineered microorganisms: Clinical implications. Molecular Pharmaceutics, 19(3), 976–984.
- Gonzalez, P., & Ramirez, F. (2019). Controlled expression systems in synthetic biology. Biochemical Engineering Journal, 148, 127–135.
- Murphy, A., & Peterson, C. (2021). Future perspectives on bioengineered microorganisms in personalized medicine. Journal of Translational Medicine, 19(1), 58.